EYPT 8-K 2026-10-19
EyePoint, Inc. (EYPT) 8-K dated 2026-10-19 — accession 0001193125-26-424755. This URL is the filing, not the EYPT hub.
EyePoint, Inc. (EYPT) is a biotechnology company listed on NASDAQ.
EYPT: SECURITIES AND EXCHANGE COMMISSION
Cached items: 2.02, 2.05, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported EYPT revenue for 2025-12-31 was $31.4M. Net income was -$232.0M. Revenue was down 27.5% from 2024-12-31 to 2025-12-31. EYPT currently screens at market cap $1.10B.
Not investment advice. The EYPT SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects that substantially all of these charges will result in cash expenditures over the same time period.
Why it matters
- expects that substantially all of these charges will result in cash expenditures over the same time period.